ANTICOAGULANTS IN ACUTE CORONARY SYNDROME

ANTICOAGULANTS IN ACUTE CORONARY SYNDROME

Clinical efficacy of unfractionated and low molecular heparins in acute coronary syndrome is discussed. New synthetic heparin derivative fondaparinux (Arixtra) is focused. Author’s brief experience of fondaparinux clinical implementation is presented.

Bibliographic Details
Main Authors: I. A. Latfullin, A. A. Podolskaya
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2009-01-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
acute coronary syndrome
anticoagulants
fondaparinux
Online Access:http://www.rpcardio.com/jour/article/view/667

Internet

http://www.rpcardio.com/jour/article/view/667

Similar Items